CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENTEquity Compensation Plan Restricted Stock Agreement • July 16th, 2021 • Cen Biotech Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 16th, 2021 Company Industry JurisdictionWHEREAS, as of June 25, 2021, the Company adopted the CEN Biotech, Inc. 2021 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and
CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENTEquity Compensation Plan Restricted Stock Agreement • July 16th, 2021 • Cen Biotech Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 16th, 2021 Company Industry JurisdictionWHEREAS, as of June 25, 2021, the Company adopted the CEN Biotech, Inc. 2021 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and
CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENTEquity Compensation Plan Restricted Stock Agreement • June 25th, 2021 • Cen Biotech Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2021 Company Industry JurisdictionWHEREAS, as of June 25, 2021, the Company adopted the CEN Biotech, Inc. 2021 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and
CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENTEquity Compensation Plan Restricted Stock Agreement • April 8th, 2021 • Cen Biotech Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 8th, 2021 Company Industry JurisdictionAGREEMENT, dated as of April 2, 2021, between CEN Biotech, Inc. (the “Company”), and CONFIEN SAS (Company registration number #901353765-9) (the “Participant”).
CEN BIOTECH, INC. 2021 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENTEquity Compensation Plan Restricted Stock Agreement • April 7th, 2021 • Cen Biotech Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 7th, 2021 Company Industry JurisdictionWHEREAS, as of April __, 2021, the Company adopted the CEN Biotech, Inc. 2021 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and
CEN BIOTECH, INC. 2017 EQUITY COMPENSATION PLAN RESTRICTED STOCK AGREEMENTEquity Compensation Plan Restricted Stock Agreement • December 5th, 2017 • Cen Biotech Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 5th, 2017 Company Industry JurisdictionWHEREAS, as of _________________ __, 2017, the Company adopted the CEN Biotech, Inc. 2017 Equity Compensation Plan (the “Plan”), which Plan authorizes, among other things, the grant of restricted shares of the Company’s common stock (“Common Stock”), to directors, officers and employees of the Company and to other individuals; and